Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 2 Similar Profiles
Pancreatic Neoplasms Medicine & Life Sciences
Adenocarcinoma Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Survival Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
irinotecan Medicine & Life Sciences
Radiotherapy Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1992 2018

Assessment of iodine uptake by pancreatic cancer following chemotherapy using dual-energy CT

Kawamoto, S., Fuld, M. K., Laheru, D., Huang, P. & Fishman, E. K. Feb 1 2018 In : Abdominal Radiology. 43, 2, p. 445-456 12 p.

Research output: Contribution to journalReview article

Pancreatic Neoplasms
Drug Therapy

Long-term analysis of 2 prospective studies that incorporate mitomycin C into an adjuvant chemoradiation regimen for pancreatic and periampullary cancers

Schunke, K. J., Rosati, L. M., Zahurak, M., Herman, J. M., Narang, A. K., Usach, I., Klein, A. P., Yeo, C. J., Korman, L. T., Hruban, R. H., Cameron, J. L., Laheru, D. A. & Abrams, R. A. Jan 1 2018 (Accepted/In press) In : Advances in Radiation Oncology.

Research output: Contribution to journalArticle

Pancreatic Neoplasms
Prospective Studies

Smad4 Loss Correlates with Higher Rates of Local and Distant Failure in Pancreatic Adenocarcinoma Patients Receiving Adjuvant Chemoradiation

Herman, J. M., Jabbour, S. K., Lin, S. H., Deek, M. P., Hsu, C. C., Fishman, E. K., Kim, S., Cameron, J. L., Chekmareva, M., Laheru, D. A., Narang, A. K., Pawlik, T. M., Hruban, R. H., Wolfgang, C. L. & Iacobuzio-Donahue, C. A. Feb 1 2018 In : Pancreas. 47, 2, p. 208-212 5 p.

Research output: Contribution to journalArticle

Confidence Intervals
Tumor Suppressor Genes

Stereotactic body radiation therapy for palliative management of pancreatic adenocarcinoma in elderly and medically inoperable patients

Ryan, J. F., Rosati, L. M., Groot, V. P., Le, D. T., Zheng, L., Laheru, D. A., Shin, E. J., Jackson, J., Moore, J., Narang, A. K. & Herman, J. M. Jan 1 2018 In : Oncotarget. 9, 23, p. 16427-16436 10 p.

Research output: Contribution to journalArticle

Disease-Free Survival
Induction Chemotherapy

A phase 1 dose-escalation and expansion study of binimetinib (MEK162), a potent and selective oral MEK1/2 inhibitor

Bendell, J. C., Javle, M., Bekaii-Saab, T. S., Finn, R. S., Wainberg, Z. A., Laheru, D. A., Weekes, C. D., Tan, B. R., Khan, G. N., Zalupski, M. M., Infante, J. R., Jones, S., Papadopoulos, K. P., Tolcher, A. W., Chavira, R. E., Christy-Bittel, J. L., Barrett, E. & Patnaik, A. Feb 28 2017 In : British Journal of Cancer. 116, 5, p. 575-583 9 p.

Research output: Contribution to journalArticle

Maximum Tolerated Dose
Biliary Tract Neoplasms